Review
doi: 10.1016/j.ijantimicag.2010.10.014.
Epub 2010 Dec 4.
Confronting multidrug-resistant Acinetobacter baumannii: a review
Affiliations
- PMID: 21130607
- DOI: 10.1016/j.ijantimicag.2010.10.014
Item in Clipboard
Review
Confronting multidrug-resistant Acinetobacter baumannii: a review
Int J Antimicrob Agents.
2011 Feb.
Abstract
Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Similar articles
-
Acinetobacter baumannii resistant to everything: what should we do?Clin Microbiol Infect. 2011 Jul;17(7):955-6. doi: 10.1111/j.1469-0691.2011.03566.x. Clin Microbiol Infect. 2011. PMID: 21722248 No abstract available.
-
Treatment of Acinetobacter infections.Expert Opin Pharmacother. 2010 Apr;11(5):779-88. doi: 10.1517/14656561003596350. Expert Opin Pharmacother. 2010. PMID: 20210684 Review.
-
[Multidrug resistant Acinetobacter baumannii].Klin Mikrobiol Infekc Lek. 2008 Oct;14(5):162-7. Klin Mikrobiol Infekc Lek. 2008. PMID: 19051163 Review. Czech.
-
Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.Diagn Microbiol Infect Dis. 2009 May;64(1):102; author reply 103. doi: 10.1016/j.diagmicrobio.2009.01.013. Epub 2009 Feb 18. Diagn Microbiol Infect Dis. 2009. PMID: 19232855 No abstract available.
-
Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.Virulence. 2011 Mar-Apr;2(2):86-90. doi: 10.4161/viru.2.2.15748. Virulence. 2011. PMID: 21499025 No abstract available.
Cited by
-
Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.Front Microbiol. 2018 May 23;9:1011. doi: 10.3389/fmicb.2018.01011. eCollection 2018. Front Microbiol. 2018. PMID: 29875743 Free PMC article.
-
Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan.BMC Infect Dis. 2013 Jul 13;13:319. doi: 10.1186/1471-2334-13-319. BMC Infect Dis. 2013. PMID: 23849336 Free PMC article.
-
Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii.Curr Microbiol. 2012 Mar;64(3):290-3. doi: 10.1007/s00284-011-0068-1. Epub 2011 Dec 24. Curr Microbiol. 2012. PMID: 22198473 Free PMC article.
-
Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection.Infect Drug Resist. 2018 Nov 15;11:2301-2310. doi: 10.2147/IDR.S179701. eCollection 2018. Infect Drug Resist. 2018. PMID: 30532563 Free PMC article. Review.
-
Acinetobacter baumannii Ventilator-Associated Pneumonia: Clinical Efficacy of Combined Antimicrobial Therapy and in vitro Drug Sensitivity Test Results.Front Pharmacol. 2019 Feb 13;10:92. doi: 10.3389/fphar.2019.00092. eCollection 2019. Front Pharmacol. 2019. PMID: 30814950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
